| ★ |  Diagnosis and management of peripheral neurological manifestations in Sjögren’s disease | | 748 | — | |
| 1 |  El Rol del Neuropsicólogo en la Práctica Clínica | | — | — | 74 |
| 13 |  Deshalb ist Ex Zurück wirklich möglich! Keine Träumerei, sondern neurobiologische Wirklichkeit! | szenario-zwei @szenariozwei | 5.4K | Austria | 70 |
| 12 |  Hydroxychloroquine in connective tissue diseases: benefits and controversial aspects | | 1.8K | — | 70 |
| 15 |  Call Barcelona Home at the FENS Forum 2026! | WebsEdgeMedicine @websedgemedicine | 801 | — | 69 |
| 4 |  LUNES EN LA CIENCIA | UAM Iztapalapa Oficial @uamiztapalapaoficial | 551 | México | 72 |
| 9 |  Steroids in Relapsing Polychondritis | | 474 | — | 70 |
| 11 |  What is the added value of triple therapy in lupus nephritis? | | 438 | — | 70 |
| 17 |  Neurodivergencia y enmascaramiento: cuando ser tú no parece suficiente. | Mundopsicologos.com @mundopsicologos | 362 | — | 69 |
| 16 |  How to explain the antiphospholipid profile to my patients? | | 300 | — | 69 |
| 10 |  2026 focus on monogenic Ehlers-Danlos syndromes: periodontal and vascular variants | | 267 | — | 70 |
| 5 |  Thrombocytopenia in systemic lupus erythematosus (SLE) | | 249 | — | 72 |
| 8 |  Exercise as a non-pharmacological treatment adjunct to pharmacotherapy in systemic sclerosis. | | 222 | — | 71 |
| 19 |  Imaging in Relapsing Polychondritis (RP) | | 171 | — | 69 |
| 2 |  Unconventional therapies in connective tissue diseases | | 110 | — | 73 |
| 14 |  Osteoporosis in rare and complex connective tissue diseases | | 96 | — | 69 |
| 7 |  Unmet Needs in Childhood-Onset Sjögren's Disease – Patient and Clinician Perspectives | | 82 | — | 71 |
| 20 |  Webinar - Accessibilità e Neurodiversità: Un connubio possibile | Sinapsi Unina @sinapsiunina | 72 | Italia | 68 |
| 18 |  Del asombro al aprendizaje con Neurodidáctica | ieducando México @ieducandomexico | 63 | México | 69 |
| 3 |  Screening and treatment of systemic sclerosis-associated PAH: where do we stand in 2024? | | 53 | — | 73 |
| 6 |  “Doctor, can you ask me…?” for connective tissue diseases patients | | 46 | — | 71 |